TABLE 1

Demographic Data and Methodologic Information Specified by Subject

Subject no.	Sex	Age (y)	Body weight (kg)	TSPO genotype	Injected activity (MBq)	Scan interval (d)	Centrifugation	Purity (%)	Plasma control (%)
1	M	61	80	MAB	120.9	21	Delayed	96.1	95.4
					117.8			93.5	91.4
2	M	70	92	MAB	112.2	42	Delayed	95.4	95.4
					123.6			94.9	93.8
3	M	59	76.5	HAB	118.1	35	Delayed	96.4	94.7
					112.0			94.9	93.2
4	F	38	110	HAB	116.3	28	Delayed	96.0	95.0
					114.3			90.7	88.4
5	F	62	70	HAB	119.0	42	Delayed	96.1	95.1
					119.4			96.6	94.0
6	F	58	50	MAB	116.0	28	Delayed	96.1	96.2
					119.7			95.3	91.4
7	F	68	87	HAB	124.8	56	Delayed	92.3	90.1
					115.1			95.2	90.5
8	M	52	94	HAB	118.5	56	Delayed	98.1	93.8
					124.1			89.8	88.5
9	M	42	80	MAB	118.8	28	Immediate	95.7	94.6
					115.8			93.4	90.3
10	F	45	86.2	MAB	117.4	56	Immediate	95.4	94.6
					114.1			94.9	94.7
11	M	35	100	HAB	119.9	56	Immediate	93.0	93.2
					114.4			90.7	89.9
12	F	40	73	MAB	112.0	7	Immediate	92.8	91.8
					130.7			94.7	94.1
13	M	24	95.6	MAB	115.4	14	Immediate	94.4	92.2
					116.0			92.0	90.2
14	F	69	83	MAB	123.0	28	Immediate	94.5	92.7
					127.1			94.4	90.4
15	F	30	68	HAB	105.8	42	Immediate	91.0	82.9
					116.0			91.1	88.1
16	F	34	74.2	HAB	118.4	28	Immediate	Not available	Not available
					116.3			Not available	Not available
Mean ± SD		49 ± 15	82.5 ± 14.4		117.9 ± 4.9	35 ± 15		93.4 ± 1.7	91.4 ± 3.2